Raras
Buscar doenças, sintomas, genes...
Miocardiopatia dilatada isolada familiar
ORPHA:154CID-10 · I42.0CID-11 · BC43.00DOENÇA RARA

É uma doença rara do músculo do coração, que é de família, caracterizada pela dilatação do ventrículo esquerdo (a câmara principal do lado esquerdo do coração) e pelo enfraquecimento progressivo da sua capacidade de bombear o sangue. Isso acontece sem que existam outras condições que sobrecarreguem o coração, ou problemas nas artérias coronárias (as artérias que nutrem o coração) que por si só justificariam essa fraqueza geral no bombeamento. A doença pode causar insuficiência cardíaca (quando o coração fica fraco) ou arritmia (quando o coração bate fora do ritmo). É considerada isolada quando não há outros sinais ou problemas incomuns no coração ou em outras partes do corpo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma doença rara do músculo do coração, que é de família, caracterizada pela dilatação do ventrículo esquerdo (a câmara principal do lado esquerdo do coração) e pelo enfraquecimento progressivo da sua capacidade de bombear o sangue. Isso acontece sem que existam outras condições que sobrecarreguem o coração, ou problemas nas artérias coronárias (as artérias que nutrem o coração) que por si só justificariam essa fraqueza geral no bombeamento. A doença pode causar insuficiência cardíaca (quando o coração fica fraco) ou arritmia (quando o coração bate fora do ritmo). É considerada isolada quando não há outros sinais ou problemas incomuns no coração ou em outras partes do corpo.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
17.5
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: I42.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
62 sintomas
💪
Músculos
6 sintomas
🫁
Pulmão
5 sintomas
🧠
Neurológico
3 sintomas
🩸
Sangue
2 sintomas
👁️
Olhos
1 sintomas

+ 27 sintomas em outras categorias

Características mais comuns

90%prev.
Disfunção sistólica do ventrículo esquerdo
Muito frequente (99-80%)
90%prev.
Cardiomiopatia dilatada
Muito frequente (99-80%)
55%prev.
Insuficiência cardíaca congestiva
Frequente (79-30%)
55%prev.
Ortopneia
Frequente (79-30%)
55%prev.
Arritmia
Frequente (79-30%)
55%prev.
Edema
Frequente (79-30%)
109sintomas
Muito frequente (2)
Frequente (6)
Ocasional (5)
Sem dados (96)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 109 características clínicas mais associadas, ordenadas por frequência.

Disfunção sistólica do ventrículo esquerdoLeft ventricular systolic dysfunction
Muito frequente (99-80%)90%
Cardiomiopatia dilatadaDilated cardiomyopathy
Muito frequente (99-80%)90%
Insuficiência cardíaca congestivaCongestive heart failure
Frequente (79-30%)55%
OrtopneiaOrthopnea
Frequente (79-30%)55%
ArritmiaArrhythmia
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos92publicações
Pico201913 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

53 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, Mitochondrial inheritance, X-linked recessive.

SCN5ASodium channel protein type 5 subunit alphaDisease-causing germline mutation(s) (gain of function) inAltamente restrito
FUNÇÃO

Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membraneCytoplasm, perinuclear regionCell membrane, sarcolemma, T-tubuleCell junction

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Progressive familial heart block 1A

A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
36.1 TPM
Coração - Ventrículo esquerdo
35.1 TPM
Cervix Ectocervix
5.3 TPM
Cervix Endocervix
4.1 TPM
Nervo tibial
2.9 TPM
OUTRAS DOENÇAS (16)
progressive familial heart block, type 1Aventricular fibrillation, paroxysmal familial, type 1sick sinus syndrome 1long QT syndrome 3
HGNC:10593UniProt:Q14524
LDB3LIM domain-binding protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May function as an adapter in striated muscle to couple protein kinase C-mediated signaling via its LIM domains to the cytoskeleton

LOCALIZAÇÃO

Cytoplasm, perinuclear regionCell projection, pseudopodiumCytoplasm, cytoskeletonCytoplasm, myofibril, sarcomere, Z line

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1C, with or without left ventricular non-compaction

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. Cardiomyopathy dilated type 1C is associated with left ventricular non-compaction in some patients. Left ventricular non-compaction is characterized by numerous prominent trabeculations and deep intertrabecular recesses in hypertrophied and hypokinetic segments of the left ventricle.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
372.3 TPM
Músculo esquelético
338.8 TPM
Coração - Átrio
299.7 TPM
Artéria tibial
89.9 TPM
Aorta
57.8 TPM
OUTRAS DOENÇAS (7)
myofibrillar myopathy 4dilated cardiomyopathy 1Cfamilial isolated arrhythmogenic ventricular dysplasia, left dominant formfamilial isolated arrhythmogenic ventricular dysplasia, biventricular form
HGNC:15710UniProt:O75112
CSRP3Cysteine and glycine-rich protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Positive regulator of myogenesis. Acts as a cofactor for myogenic bHLH transcription factors such as MYOD1, and probably MYOG and MYF6. Enhances the DNA-binding activity of the MYOD1:TCF3 isoform E47 complex and may promote formation of a functional MYOD1:TCF3 isoform E47:MEF2A complex involved in myogenesis (By similarity). Plays a crucial and specific role in the organization of cytosolic structures in cardiomyocytes. Could play a role in mechanical stretch sensing. May be a scaffold protein t

LOCALIZAÇÃO

NucleusCytoplasmCytoplasm, cytoskeletonCytoplasm, myofibril, sarcomere, Z lineCytoplasm, myofibril, sarcomere

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1M

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
750.4 TPM
Coração - Átrio
603.9 TPM
Músculo esquelético
236.4 TPM
Glândula salivar
0.9 TPM
Testículo
0.5 TPM
OUTRAS DOENÇAS (3)
hypertrophic cardiomyopathy 12dilated cardiomyopathy 1Mfamilial isolated dilated cardiomyopathy
HGNC:2472UniProt:P50461
FHL2Four and a half LIM domains protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May function as a molecular transmitter linking various signaling pathways to transcriptional regulation. Negatively regulates the transcriptional repressor E4F1 and may function in cell growth. Inhibits the transcriptional activity of FOXO1 and its apoptotic function by enhancing the interaction of FOXO1 with SIRT1 and FOXO1 deacetylation. Negatively regulates the calcineurin/NFAT signaling pathway in cardiomyocytes (PubMed:28717008)

LOCALIZAÇÃO

CytoplasmNucleusCytoplasm, myofibril, sarcomere, Z line

VIAS BIOLÓGICAS (1)
PPARA activates gene expression
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
246.6 TPM
Coração - Ventrículo esquerdo
171.3 TPM
Fibroblastos
55.8 TPM
Cervix Endocervix
51.9 TPM
Coração - Átrio
45.6 TPM
OUTRAS DOENÇAS (1)
familial isolated dilated cardiomyopathy
HGNC:3703UniProt:Q14192
TNNC1Troponin I, cardiac muscleDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Troponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 7

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
5931.5 TPM
Coração - Ventrículo esquerdo
3604.0 TPM
Coração - Átrio
1693.5 TPM
Nervo tibial
189.2 TPM
Pulmão
64.9 TPM
OUTRAS DOENÇAS (3)
dilated cardiomyopathy 1Zhypertrophic cardiomyopathy 13familial isolated dilated cardiomyopathy
HGNC:11943UniProt:P19429
TNNT2Troponin T, cardiac muscleDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 2

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
2785.9 TPM
Coração - Átrio
2374.2 TPM
Nervo tibial
27.9 TPM
Brain Frontal Cortex BA9
20.2 TPM
Rim - Córtex
18.5 TPM
OUTRAS DOENÇAS (7)
cardiomyopathy, familial restrictive, 3dilated cardiomyopathy 1Dhypertrophic cardiomyopathy 2hypertrophic cardiomyopathy
HGNC:11949UniProt:P45379
SDHASuccinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Flavoprotein (FP) subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q) (PubMed:10746566, PubMed:24781757). SDH also oxidizes malate to the non-canonical enol form of oxaloacetate, enol-oxaloacetate (By similarity). Enol-oxaloacetate, which is a potent inhibitor of the succinate dehydrogenase activity, is further isomerized into keto-oxaloacetate

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Maturation of TCA enzymes and regulation of TCA cycle
MECANISMO DE DOENÇA

Mitochondrial complex II deficiency, nuclear type 1

A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations. Clinical features include psychomotor regression in infants, poor growth with lack of speech development, severe spastic quadriplegia, dystonia, progressive leukoencephalopathy, muscle weakness, exercise intolerance, cardiomyopathy. Some patients manifest Leigh syndrome or Kearns-Sayre syndrome. MC2DN1 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
302.0 TPM
Músculo esquelético
237.6 TPM
Coração - Átrio
206.8 TPM
Glândula adrenal
172.2 TPM
Linfócitos
168.3 TPM
OUTRAS DOENÇAS (9)
mitochondrial complex II deficiency, nuclear type 1pheochromocytoma/paraganglioma syndrome 5neurodegeneration with ataxia and late-onset optic atrophydilated cardiomyopathy 1GG
HGNC:10680UniProt:P31040
RBM20RNA-binding protein 20Disease-causing germline mutation(s) inRestrito
FUNÇÃO

RNA-binding protein that acts as a regulator of mRNA splicing of a subset of genes encoding key structural proteins involved in cardiac development, such as TTN (Titin), CACNA1C, CAMK2D or PDLIM5/ENH (PubMed:22466703, PubMed:24960161, PubMed:26604136, PubMed:27496873, PubMed:27531932, PubMed:29895960, PubMed:30948719, PubMed:32840935, PubMed:34732726, PubMed:35427468). Acts as a repressor of mRNA splicing: specifically binds the 5'UCUU-3' motif that is predominantly found within intronic sequenc

LOCALIZAÇÃO

NucleusCytoplasm, Cytoplasmic ribonucleoprotein granule

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1DD

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
29.9 TPM
Coração - Átrio
25.8 TPM
Aorta
13.4 TPM
Artéria coronária
12.9 TPM
Pâncreas
10.6 TPM
OUTRAS DOENÇAS (2)
dilated cardiomyopathy 1DDfamilial isolated dilated cardiomyopathy
HGNC:27424UniProt:Q5T481
ACTN2Alpha-actinin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein

LOCALIZAÇÃO

Cytoplasm, myofibril, sarcomere, Z line

VIAS BIOLÓGICAS (8)
RAF/MAP kinase cascadeRas activation upon Ca2+ influx through NMDA receptorUnblocking of NMDA receptors, glutamate binding and activationLong-term potentiationNegative regulation of NMDA receptor-mediated neuronal transmission
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 23, with or without left ventricular non-compaction

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

OUTRAS DOENÇAS (4)
myopathy, distal, 6, adult-onset, autosomal dominantmyopathy, congenital, with structured cores and z-line abnormalitiesdilated cardiomyopathy 1AAfamilial isolated dilated cardiomyopathy
HGNC:164UniProt:P35609
RAF1RAF proto-oncogene serine/threonine-protein kinaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and

LOCALIZAÇÃO

CytoplasmCell membraneMitochondrionNucleus

VIAS BIOLÓGICAS (5)
IFNG signaling activates MAPKsCD209 (DC-SIGN) signalingStimuli-sensing channelsGP1b-IX-V activation signallingRap1 signalling
MECANISMO DE DOENÇA

Noonan syndrome 5

A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
152.2 TPM
Artéria tibial
139.4 TPM
Cérebro - Hemisfério cerebelar
134.9 TPM
Sangue
131.1 TPM
Ovário
129.4 TPM
OUTRAS DOENÇAS (9)
Noonan syndrome 5LEOPARD syndrome 2dilated cardiomyopathy 1NNNoonan syndrome
HGNC:9829UniProt:P04049
C10ORF71Cardiac-enriched FHL2-interacting proteinDisease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Is an activator of the calcineurin/NFAT signaling pathway in cardiomyocytes, and is involved in myocardium morphogenesis, and regulation of myocardium mass and cardiac contractile function

LOCALIZAÇÃO

Cytoplasm, myofibril, sarcomere, Z line

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1QQ

A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD1QQ is an autosomal dominant form.

INTERAÇÕES PROTEICAS (2)
HGNC:26973UniProt:Q711Q0
HAND2Heart- and neural crest derivatives-expressed protein 2Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Essential for cardiac morphogenesis, particularly for the formation of the right ventricle and of the aortic arch arteries. Required for vascular development and regulation of angiogenesis, possibly through a VEGF signaling pathway. Also plays an important role in limb development, particularly in the establishment of anterior-posterior polarization, acting as an upstream regulator of sonic hedgehog (SHH) induction in the limb bud. Is involved in the development of branchial arches, which give r

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Transcriptional regulation by RUNX2Cardiogenesis
EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
178.1 TPM
Útero
86.4 TPM
Cervix Endocervix
81.7 TPM
Esôfago - Muscular
73.8 TPM
Cervix Ectocervix
70.4 TPM
OUTRAS DOENÇAS (1)
familial isolated dilated cardiomyopathy
HGNC:4808UniProt:P61296
CAP2Adenylyl cyclase-associated protein 2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Involved in the regulation of actin polymerization

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Role of ABL in ROBO-SLIT signaling
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 2I

A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD2I is an autosomal recessive, severe form characterized by onset in infancy or childhood.

OUTRAS DOENÇAS (2)
cardiomyopathy, dilated, 2Ifamilial isolated dilated cardiomyopathy
HGNC:20039UniProt:P40123
LMOD2Leiomodin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Mediates nucleation of actin filaments and thereby promotes actin polymerization (PubMed:18403713, PubMed:25250574, PubMed:26370058, PubMed:26417072). Plays a role in the regulation of actin filament length (By similarity). Required for normal sarcomere organization in the heart, and for normal heart function (PubMed:18403713)

LOCALIZAÇÃO

Cytoplasm, myofibril, sarcomereCytoplasm, myofibrilCytoplasm, myofibril, sarcomere, M lineCytoplasm, cytoskeleton

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 2G

A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD2G is an autosomal recessive form characterized by early-onset, severe cardiomyopathy that progresses rapidly to heart failure in the neonatal period without evidence of intervening hypertrophy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
396.6 TPM
Coração - Ventrículo esquerdo
223.9 TPM
Coração - Átrio
197.3 TPM
Glândula salivar
0.7 TPM
Testículo
0.7 TPM
OUTRAS DOENÇAS (2)
cardiomyopathy, dilated, 2Gfamilial isolated dilated cardiomyopathy
HGNC:6648UniProt:Q6P5Q4
DSG2Desmoglein-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:17559062, PubMed:38395410). Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion. Required for proliferation and viability of embryonic stem cells in the blastocyst, thereby crucial for progression of post-implantation embryonic development (By similarity). Maintains pluripotency by regulating epithelial to mesenchymal transition/m

LOCALIZAÇÃO

Cell membraneCell junction, desmosomeCytoplasm

VIAS BIOLÓGICAS (6)
Apoptotic cleavage of cell adhesion proteinsKeratinizationFormation of the cornified envelopeRAC3 GTPase cycleRHOG GTPase cycle
MECANISMO DE DOENÇA

Arrhythmogenic right ventricular dysplasia, familial, 10

A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
42.9 TPM
Cólon transverso
37.5 TPM
Mama
34.1 TPM
Adipose Visceral Omentum
25.6 TPM
Intestino delgado
25.6 TPM
OUTRAS DOENÇAS (6)
dilated cardiomyopathy 1BBarrhythmogenic right ventricular dysplasia 10familial isolated arrhythmogenic ventricular dysplasia, left dominant formfamilial isolated arrhythmogenic ventricular dysplasia, biventricular form
HGNC:3049UniProt:Q14126
GET3ATPase GET3Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

ATPase required for the post-translational delivery of tail-anchored (TA) proteins to the endoplasmic reticulum (PubMed:17382883). Recognizes and selectively binds the transmembrane domain of TA proteins in the cytosol. This complex then targets to the endoplasmic reticulum by membrane-bound receptors GET1/WRB and CAMLG/GET2, where the tail-anchored protein is released for insertion. This process is regulated by ATP binding and hydrolysis. ATP binding drives the homodimer towards the closed dime

LOCALIZAÇÃO

CytoplasmEndoplasmic reticulumNucleus, nucleolus

VIAS BIOLÓGICAS (1)
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 2H

A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD2H is an autosomal recessive form characterized by rapid progression and death in early infancy.

OUTRAS DOENÇAS (2)
cardiomyopathy, dilated, 2Hfamilial isolated dilated cardiomyopathy
HGNC:752UniProt:O43681
SGCDDelta-sarcoglycanDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 6

An autosomal recessive degenerative myopathy initially affecting the proximal limb girdle musculature. Muscle from patients shows a complete loss of delta-sarcoglycan as well as of the others components of the sarcoglycan complex.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
26.6 TPM
Aorta
20.2 TPM
Músculo esquelético
15.2 TPM
Esôfago - Junção
14.2 TPM
Coração - Átrio
12.8 TPM
OUTRAS DOENÇAS (4)
autosomal recessive limb-girdle muscular dystrophy type 2Fdilated cardiomyopathy 1Lautosomal recessive limb-girdle muscular dystrophyfamilial isolated dilated cardiomyopathy
HGNC:10807UniProt:Q92629
VEZF1Vascular endothelial zinc finger 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Possible transcription factor. Specifically binds to the CT/GC-rich region of the interleukin-3 promoter and mediates tax transactivation of IL-3

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1OO

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD1OO inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
58.5 TPM
Cervix Endocervix
54.5 TPM
Cólon sigmoide
53.5 TPM
Fallopian Tube
49.5 TPM
Esôfago - Muscular
48.5 TPM
OUTRAS DOENÇAS (2)
cardiomyopathy, dilated, 100familial isolated dilated cardiomyopathy
HGNC:12949UniProt:Q14119
FKTNRibitol-5-phosphate transferase FKTNDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the transfer of a ribitol-phosphate from CDP-ribitol to the distal N-acetylgalactosamine of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1) (PubMed:26923585, PubMed:27194101, PubMed:29477842). This constitutes the first step in the formation of the ribitol 5-phosphate tandem repeat which links the phosphorylated O-mannosyl trisaccharide to the ligan

LOCALIZAÇÃO

Golgi apparatus membraneCytoplasmNucleus

VIAS BIOLÓGICAS (1)
Matriglycan biosynthesis on DAG1
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A4

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
21.9 TPM
Nervo tibial
12.9 TPM
Ovário
12.1 TPM
Útero
10.6 TPM
Cérebro - Hemisfério cerebelar
10.4 TPM
OUTRAS DOENÇAS (8)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4autosomal recessive limb-girdle muscular dystrophy type 2Mmuscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4dilated cardiomyopathy 1X
HGNC:3622UniProt:O75072
PPCSPhosphopantothenate--cysteine ligaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the second step in the biosynthesis of coenzyme A from vitamin B5, where cysteine is conjugated to 4'-phosphopantothenate to form 4-phosphopantothenoylcysteine (PubMed:11923312, PubMed:12906824, PubMed:29754768). Has a preference for ATP over CTP as a cosubstrate (PubMed:11923312)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Coenzyme A biosynthesis
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 2C

A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD2C is an autosomal recessive form with variable severity and age of onset ranging from 2 to 20 years. Death in infancy or early childhood may occur in severely affected children.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
50.8 TPM
Tireoide
50.8 TPM
Próstata
48.8 TPM
Linfócitos
47.5 TPM
Tecido adiposo
47.0 TPM
OUTRAS DOENÇAS (2)
cardiomyopathy, dilated, 2cfamilial isolated dilated cardiomyopathy
HGNC:25686UniProt:Q9HAB8
DSPDesmoplakinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25733715). Critical for cell-cell adhesion in early stage blastocysts and progression through proamniotic cavity formation (By similarity). Not required for preimplantation morphogenic process in blastocysts (By similarity). Required for keratin filament anchoring at the desmosome junction and subsequent organization of the keratin intermediate filament network within the cytoplas

LOCALIZAÇÃO

Cell projection, axonCell junction, desmosomeCell membraneCytoplasmNucleus

VIAS BIOLÓGICAS (6)
Apoptotic cleavage of cell adhesion proteinsNeutrophil degranulationKeratinizationFormation of the cornified envelopeRND1 GTPase cycle
MECANISMO DE DOENÇA

Keratoderma, palmoplantar, striate 2

A dermatological disorder characterized by thickening of the skin on the palms (linear pattern) and the soles (island-like pattern) and flexor aspect of the fingers. Abnormalities of the nails, the teeth and the hair are rarely present.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
1294.4 TPM
Skin Not Sun Exposed Suprapubic
1155.3 TPM
Esôfago - Mucosa
647.4 TPM
Vagina
416.9 TPM
Glândula salivar
87.7 TPM
OUTRAS DOENÇAS (13)
arrhythmogenic cardiomyopathy with wooly hair and keratodermakeratosis palmoplantaris striata 2lethal acantholytic epidermolysis bullosacardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis
HGNC:3052UniProt:P15924
PSEN1Presenilin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:10206644, PubMed:10545183, PubMed:10593990, PubMed:10811883, PubMed:10899933, PubMed:12679784, PubMed:12740439, PubMed:15274632, PubMed:20460383, PubMed:25043039, PubMed:26280335, PubMed:28269784, PubMed:30598546, PubMed:30630874). Requires the presence of the other members of the

LOCALIZAÇÃO

Endoplasmic reticulumEndoplasmic reticulum membraneGolgi apparatus membraneCytoplasmic granuleCell membraneCell projection, growth coneEarly endosomeEarly endosome membraneCell projection, neuron projectionCell projection, axonSynapse

VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Alzheimer disease 3

A familial early-onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
39.3 TPM
Skin Sun Exposed Lower leg
25.1 TPM
Skin Not Sun Exposed Suprapubic
22.8 TPM
Nervo tibial
20.5 TPM
Fibroblastos
19.7 TPM
OUTRAS DOENÇAS (9)
semantic dementiaPick diseaseAlzheimer disease 3acne inversa, familial, 3
HGNC:9508UniProt:P49768
JPH2Junctophilin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Membrane-binding protein that provides a structural bridge between the plasma membrane and the sarcoplasmic reticulum and is required for normal excitation-contraction coupling in cardiomyocytes (PubMed:20095964). Provides a structural foundation for functional cross-talk between the cell surface and intracellular Ca(2+) release channels by maintaining the 12-15 nm gap between the sarcolemma and the sarcoplasmic reticulum membranes in the cardiac dyads (By similarity). Necessary for proper intra

LOCALIZAÇÃO

Cell membraneSarcoplasmic reticulum membraneEndoplasmic reticulum membraneNucleus

MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 17

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
131.8 TPM
Esôfago - Junção
108.5 TPM
Útero
100.0 TPM
Artéria tibial
97.3 TPM
Cólon sigmoide
97.1 TPM
OUTRAS DOENÇAS (3)
cardiomyopathy, dilated, 2Ehypertrophic cardiomyopathy 17familial isolated dilated cardiomyopathy
HGNC:14202UniProt:Q9BR39
PRDM16Histone-lysine N-methyltransferase PRDM16Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription regulator that acts both as a histone methyltransferase or chromatin adapter, depending on the context (PubMed:12816872). In the cytoplasm, acts as a histone methyltransferase, which catalyzes monomethylation of 'Lys-9' of free histone H3 (H3K9me1) during translation (By similarity). Monomethylated histone H3 is then transported to the nucleus and incorporated into nucleosomes where SUV39H methyltransferases (SUV39H1 and SUV39H2) use it as a substrate to catalyze histone H3 'Lys-9'

LOCALIZAÇÃO

NucleusChromosomeCytoplasm

VIAS BIOLÓGICAS (1)
PKMTs methylate histone lysines
MECANISMO DE DOENÇA

Left ventricular non-compaction 8

A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC8 is an autosomal dominant condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
37.2 TPM
Artéria tibial
30.3 TPM
Artéria coronária
24.6 TPM
Nervo tibial
20.5 TPM
Tireoide
18.6 TPM
OUTRAS DOENÇAS (4)
left ventricular noncompaction 8chromosome 1p36 deletion syndromefamilial isolated dilated cardiomyopathyleft ventricular noncompaction
HGNC:14000UniProt:Q9HAZ2
LMNAPrelamin-A/CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:2188730, PubMed:22431096, PubMed:2344612, PubMed:23666920, PubMed:24741066, PubMed:31434876, PubMed:

LOCALIZAÇÃO

Nucleus laminaNucleus envelopeNucleus, nucleoplasmNucleus matrixNucleus speckle

VIAS BIOLÓGICAS (1)
Initiation of Nuclear Envelope (NE) Reformation
MECANISMO DE DOENÇA

Emery-Dreifuss muscular dystrophy 2, autosomal dominant

A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
392.7 TPM
Aorta
300.6 TPM
Skin Not Sun Exposed Suprapubic
297.7 TPM
Skin Sun Exposed Lower leg
272.6 TPM
Útero
255.8 TPM
OUTRAS DOENÇAS (23)
restrictive dermopathy 2familial partial lipodystrophy, Dunnigan typedilated cardiomyopathy-hypergonadotropic hypogonadism syndromemandibuloacral dysplasia with type A lipodystrophy
HGNC:6636UniProt:P02545
MYBPC3Myosin-binding protein C, cardiac-typeDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 4

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
1351.0 TPM
Coração - Átrio
991.7 TPM
Sangue
7.7 TPM
Baço
4.9 TPM
Testículo
4.1 TPM
OUTRAS DOENÇAS (5)
left ventricular noncompaction 10hypertrophic cardiomyopathy 4hypertrophic cardiomyopathyfamilial isolated dilated cardiomyopathy
HGNC:7551UniProt:Q14896
TNNI3Troponin I, cardiac muscleDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Troponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity

LOCALIZAÇÃO

VIAS BIOLÓGICAS (2)
Ion homeostasisStriated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 7

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
4483.4 TPM
Coração - Átrio
2182.1 TPM
Testículo
19.3 TPM
Músculo esquelético
4.8 TPM
Skin Not Sun Exposed Suprapubic
3.4 TPM
OUTRAS DOENÇAS (7)
dilated cardiomyopathy 1FFcardiomyopathy, familial restrictive, 1hypertrophic cardiomyopathy 7dilated cardiomyopathy 2A
HGNC:11947UniProt:P19429
MYPNMyopalladinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the sarcomere that tethers together nebulin (skeletal muscle) and nebulette (cardiac muscle) to alpha-actinin, at the Z lines

LOCALIZAÇÃO

CytoplasmNucleusCytoplasm, myofibril, sarcomereCytoplasm, myofibril, sarcomere, Z line

MECANISMO DE DOENÇA

Congenital myopathy 24

An autosomal recessive muscular disorder characterized by slowly progressive muscle weakness and atrophy, mainly affecting the lower limbs and neck. Some patients may have mild cardiac or respiratory involvement, but they do not have respiratory failure. Muscle biopsy shows nemaline bodies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
118.8 TPM
Coração - Ventrículo esquerdo
28.4 TPM
Coração - Átrio
26.0 TPM
Fibroblastos
6.2 TPM
Testículo
1.4 TPM
OUTRAS DOENÇAS (6)
MYPN-related myopathydilated cardiomyopathy 1KKfamilial isolated dilated cardiomyopathycap myopathy
HGNC:23246UniProt:Q86TC9
TAF1ATATA box-binding protein-associated factor RNA polymerase I subunit ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (pre-initiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits

LOCALIZAÇÃO

Nucleus, nucleolus

VIAS BIOLÓGICAS (6)
RNA Polymerase I Promoter EscapeNoRC negatively regulates rRNA expressionRNA Polymerase I Transcription TerminationRNA Polymerase I Transcription InitiationSIRT1 negatively regulates rRNA expression
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
7.5 TPM
Fibroblastos
7.3 TPM
Testículo
6.6 TPM
Ovário
6.5 TPM
Cervix Ectocervix
5.6 TPM
OUTRAS DOENÇAS (1)
familial isolated dilated cardiomyopathy
HGNC:11532UniProt:Q15573
ACTC1Actin, alpha cardiac muscle 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (5)
Regulation of CDH1 FunctionFormation of the dystrophin-glycoprotein complex (DGC)Striated Muscle ContractionRHOB GTPase cycleRHOA GTPase cycle
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1R

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

OUTRAS DOENÇAS (7)
atrial septal defect 5dilated cardiomyopathy 1Rhypertrophic cardiomyopathy 11hypertrophic cardiomyopathy
HGNC:143UniProt:P68032
CRYABAlpha-crystallin B chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May contribute to the transparency and refractive index of the lens. Has chaperone-like activity, preventing aggregation of various proteins under a wide range of stress conditions. In lens epithelial cells, stabilizes the ATP6V1A protein, preventing its degradation by the proteasome (By similarity)

LOCALIZAÇÃO

CytoplasmNucleusSecretedLysosome

VIAS BIOLÓGICAS (1)
HSF1-dependent transactivation
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 2A, adult-onset

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM2A is an autosomal dominant form characterized by weakness of the proximal and distal limb muscles, weakness of the neck, velopharynx and trunk muscles, respiratory insufficiency, hypertrophic cardiomyopathy, and cataract.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
1863.3 TPM
Brain Spinal cord cervical c-1
1663.2 TPM
Coração - Átrio
1591.1 TPM
Músculo esquelético
1435.1 TPM
Nervo tibial
1093.8 TPM
OUTRAS DOENÇAS (8)
fatal infantile hypertonic myofibrillar myopathymyofibrillar myopathy 2dilated cardiomyopathy 1IIcataract 16 multiple types
HGNC:2389UniProt:P02511
RPL3LRibosomal protein uL3-likeDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Heart- and skeletal muscle-specific component of the ribosome, which regulates muscle function. Component of the large ribosomal subunit in striated muscle cells: replaces the RPL3 paralog in the ribosome in these cells. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. Inhibits myotube growth and muscle function

LOCALIZAÇÃO

VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 2D

A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD2D is an autosomal recessive, severe form with neonatal onset.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
262.7 TPM
Coração - Ventrículo esquerdo
101.0 TPM
Coração - Átrio
15.7 TPM
Testículo
13.8 TPM
Pâncreas
0.6 TPM
OUTRAS DOENÇAS (2)
cardiomyopathy, dilated, 2Dfamilial isolated dilated cardiomyopathy
HGNC:10351UniProt:Q92901
ANKRD1Ankyrin repeat domain-containing protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play an important role in endothelial cell activation. May act as a nuclear transcription factor that negatively regulates the expression of cardiac genes. Induction seems to be correlated with apoptotic cell death in hepatoma cells

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
PPARA activates gene expression
OUTRAS DOENÇAS (1)
familial isolated dilated cardiomyopathy
HGNC:15819UniProt:Q15327
TMPOLamina-associated polypeptide 2, isoform alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. Plays an important role, together with LMNA, in the nuclear anchorage of RB1 TP and TP5 may play a role in T-cell development and function. TP5 is an immunomodulating pentapeptide

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (10)
RAC3 GTPase cycleRHOJ GTPase cycleRHOG GTPase cycleRHOF GTPase cycleRAC1 GTPase cycle
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
95.5 TPM
Ovário
44.7 TPM
Fibroblastos
29.4 TPM
Útero
29.1 TPM
Cervix Endocervix
29.0 TPM
OUTRAS DOENÇAS (1)
familial isolated dilated cardiomyopathy
HGNC:11875UniProt:P42166
BAG5BAG family molecular chaperone regulator 5Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Co-chaperone for HSP/HSP70 proteins. It functions as a nucleotide-exchange factor promoting the release of ADP from HSP70, thereby activating HSP70-mediated protein refolding (PubMed:20223214). Has an essential role in maintaining proteostasis at junctional membrane complexes (JMC), where it may function as a scaffold between the HSPA8 chaperone and JMC proteins enabling correct, HSPA8-dependent JMC protein folding (By similarity). Inhibits both auto-ubiquitination of PRKN and ubiquitination of

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Regulation of HSF1-mediated heat shock response
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 2F

A form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. CMD2F is an autosomal recessive, early-onset form.

OUTRAS DOENÇAS (2)
cardiomyopathy, dilated, 2Ffamilial isolated dilated cardiomyopathy
HGNC:941UniProt:Q9UL15
PLNPhospholambanDisease-causing germline mutation(s) inModerado
FUNÇÃO

Reversibly inhibits the activity of ATP2A2/SERCA2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+) (PubMed:28890335). Binds preferentially to the ATP-bound E1 conformational form of ATP2A2 which predominates at low Ca(2+) concentrations during the diastolic phase of the cardiac cycle (By similarity). Inhibits ATP2A2 Ca(2+) affinity by disrupting its allosteric activation by ATP (By similarity). Modulates the contractility of the heart muscle in respo

LOCALIZAÇÃO

Endoplasmic reticulum membraneSarcoplasmic reticulum membraneMitochondrion membraneMembrane

VIAS BIOLÓGICAS (2)
Ion homeostasisIon transport by P-type ATPases
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1P

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
902.6 TPM
Coração - Ventrículo esquerdo
804.3 TPM
Aorta
764.7 TPM
Artéria coronária
567.4 TPM
Coração - Átrio
508.7 TPM
OUTRAS DOENÇAS (4)
hypertrophic cardiomyopathy 18dilated cardiomyopathy 1Pfamilial isolated dilated cardiomyopathyfamilial isolated arrhythmogenic ventricular dysplasia, right dominant form
HGNC:9080UniProt:P26678
TCAPTelethoninDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Muscle assembly regulating factor. Mediates the antiparallel assembly of titin (TTN) molecules at the sarcomeric Z-disk

LOCALIZAÇÃO

Cytoplasm, myofibril, sarcomere

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 25

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
2504.5 TPM
Coração - Ventrículo esquerdo
1812.2 TPM
Coração - Átrio
1252.5 TPM
Cerebelo
14.4 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
OUTRAS DOENÇAS (3)
autosomal recessive limb-girdle muscular dystrophy type 2Ghypertrophic cardiomyopathy 25familial isolated dilated cardiomyopathy
HGNC:11610UniProt:O15273
GATAD1GATA zinc finger domain-containing protein 1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Component of some chromatin complex recruited to chromatin sites methylated 'Lys-4' of histone H3 (H3K4me), with a preference for trimethylated form (H3K4me3)

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 2B

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
88.5 TPM
Cervix Endocervix
82.8 TPM
Fallopian Tube
77.1 TPM
Tireoide
69.9 TPM
Cervix Ectocervix
68.5 TPM
OUTRAS DOENÇAS (2)
dilated cardiomyopathy 2Bfamilial isolated dilated cardiomyopathy
HGNC:29941UniProt:Q8WUU5
DOLKDolichol kinaseDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Catalyzes CTP-mediated phosphorylation of dolichol, the terminal step in de novo dolichyl monophosphate (Dol-P) biosynthesis (PubMed:12213788, PubMed:16923818, PubMed:17273964, PubMed:22242004). Dol-P is a lipid carrier essential for the synthesis of N-linked and O-linked oligosaccharides and for GPI anchors (PubMed:12213788)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of dolichyl-phosphate
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1M

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. CDG1M is a very severe disease with death occurring in early life.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
35.3 TPM
Fibroblastos
32.5 TPM
Glândula adrenal
23.3 TPM
Útero
18.7 TPM
Cervix Endocervix
18.5 TPM
OUTRAS DOENÇAS (2)
DK1-congenital disorder of glycosylationfamilial isolated dilated cardiomyopathy
HGNC:23406UniProt:Q9UPQ8
TTNTitinDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Key component in the assembly and functioning of vertebrate striated muscles. By providing connections at the level of individual microfilaments, it contributes to the fine balance of forces between the two halves of the sarcomere. The size and extensibility of the cross-links are the main determinants of sarcomere extensibility properties of muscle. In non-muscle cells, seems to play a role in chromosome condensation and chromosome segregation during mitosis. Might link the lamina network to ch

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Platelet degranulation
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 9, with early respiratory failure

An autosomal dominant myopathy characterized by adulthood onset of weakness in proximal, distal, axial and respiratory muscles. Pelvic girdle weakness, foot drop and neck weakness are the main symptoms at onset, but ultimately the weakness usually involves the proximal compartment of both upper and lower limbs. Additional features include variable degrees of Achilles tendon contractures, spinal rigidity and muscle hypertrophy. Respiratory involvement often leads to requirement for non-invasive ventilation support.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
358.5 TPM
Coração - Ventrículo esquerdo
66.8 TPM
Coração - Átrio
56.9 TPM
Testículo
1.6 TPM
Pulmão
1.0 TPM
OUTRAS DOENÇAS (14)
autosomal recessive limb-girdle muscular dystrophy type 2Jmyopathy, myofibrillar, 9, with early respiratory failureearly-onset myopathy with fatal cardiomyopathydilated cardiomyopathy 1G
HGNC:12403UniProt:Q8WZ42
VCLVinculinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Actin filament (F-actin)-binding protein involved in cell-matrix adhesion and cell-cell adhesion. Regulates cell-surface E-cadherin expression and potentiates mechanosensing by the E-cadherin complex. May also play important roles in cell morphology and locomotion

LOCALIZAÇÃO

Cell membraneCell junction, adherens junctionCell junction, focal adhesionCytoplasm, cytoskeletonCell membrane, sarcolemmaCell projection, podosomeCytoplasm, perinuclear region

VIAS BIOLÓGICAS (10)
Paradoxical activation of RAF signaling by kinase inactive BRAFSignaling by moderate kinase activity BRAF mutantsSignaling by high-kinase activity BRAF mutantsSignaling downstream of RAS mutantsMAP2K and MAPK activation
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1W

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
319.4 TPM
Aorta
260.8 TPM
Cólon sigmoide
237.8 TPM
Esôfago - Muscular
228.3 TPM
Útero
216.6 TPM
OUTRAS DOENÇAS (3)
hypertrophic cardiomyopathy 15dilated cardiomyopathy 1Wfamilial isolated dilated cardiomyopathy
HGNC:12665UniProt:P18206
NEXNNexilinDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Involved in regulating cell migration through association with the actin cytoskeleton. Has an essential role in the maintenance of Z line and sarcomere integrity

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell junction, adherens junctionCytoplasm, myofibril, sarcomere, Z line

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1CC

An autosomal dominant form of dilated cardiomyopathy, a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
262.7 TPM
Artéria tibial
242.5 TPM
Aorta
238.7 TPM
Esôfago - Muscular
180.4 TPM
Artéria coronária
178.4 TPM
OUTRAS DOENÇAS (3)
dilated cardiomyopathy 1CChypertrophic cardiomyopathy 20familial isolated dilated cardiomyopathy
HGNC:29557UniProt:Q0ZGT2
DMDDystrophinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, cytoskeletonPostsynaptic cell membrane

VIAS BIOLÓGICAS (3)
Formation of the dystrophin-glycoprotein complex (DGC)Non-integrin membrane-ECM interactionsStriated Muscle Contraction
MECANISMO DE DOENÇA

Duchenne muscular dystrophy

Most common form of muscular dystrophy; a sex-linked recessive disorder. It typically presents in boys aged 3 to 7 year as proximal muscle weakness causing waddling gait, toe-walking, lordosis, frequent falls, and difficulty in standing up and climbing up stairs. The pelvic girdle is affected first, then the shoulder girdle. Progression is steady and most patients are confined to a wheelchair by age of 10 or 12. Flexion contractures and scoliosis ultimately occur. About 50% of patients have a lower IQ than their genetic expectations would suggest. There is no treatment.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
44.5 TPM
Artéria tibial
28.2 TPM
Aorta
27.2 TPM
Cólon sigmoide
25.6 TPM
Músculo esquelético
23.1 TPM
OUTRAS DOENÇAS (6)
Duchenne muscular dystrophyBecker muscular dystrophydilated cardiomyopathy 3Bsymptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
HGNC:2928UniProt:P11532
LAMA4Laminin subunit alpha-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membraneSecreted

VIAS BIOLÓGICAS (7)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactionsNon-integrin membrane-ECM interactions
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1JJ

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
268.6 TPM
Esôfago - Muscular
146.0 TPM
Nervo tibial
132.8 TPM
Fallopian Tube
120.0 TPM
Adipose Visceral Omentum
114.2 TPM
OUTRAS DOENÇAS (2)
dilated cardiomyopathy 1JJfamilial isolated dilated cardiomyopathy
HGNC:6484UniProt:Q16363
DESDesminDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Muscle-specific type III intermediate filament essential for proper muscular structure and function. Plays a crucial role in maintaining the structure of sarcomeres, inter-connecting the Z-disks and forming the myofibrils, linking them not only to the sarcolemmal cytoskeleton, but also to the nucleus and mitochondria, thus providing strength for the muscle fiber during activity (PubMed:25358400). In adult striated muscle they form a fibrous network connecting myofibrils to each other and to the

LOCALIZAÇÃO

Cytoplasm, myofibril, sarcomere, Z lineCytoplasmCell membrane, sarcolemmaNucleusCell tipNucleus envelope

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 1

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM1 is characterized by skeletal muscle weakness associated with cardiac conduction blocks, arrhythmias, restrictive heart failure, and accumulation of desmin-reactive deposits in cardiac and skeletal muscle cells.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
14058.1 TPM
Cólon sigmoide
13011.1 TPM
Músculo esquelético
12069.4 TPM
Esôfago - Junção
10253.3 TPM
Coração - Ventrículo esquerdo
8346.0 TPM
OUTRAS DOENÇAS (4)
myofibrillar myopathy 1neurogenic scapuloperoneal syndrome, Kaeser typedilated cardiomyopathy 1Ifamilial isolated dilated cardiomyopathy
HGNC:2770UniProt:P17661
PSEN2Presenilin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:10497236, PubMed:10652302, PubMed:16752394, PubMed:27293189, PubMed:36272978). Selectively cleaves late endosomal/lysosomal localized substrates and generates the prominent pool of intracellular amyloid beta that contains longer amyloid beta (PubMed:27293189). The holoprotein func

LOCALIZAÇÃO

Endoplasmic reticulum membraneGolgi apparatus membraneLate endosome membraneLysosome membrane

VIAS BIOLÓGICAS (10)
Activated NOTCH1 Transmits Signal to the NucleusNOTCH3 Activation and Transmission of Signal to the NucleusNOTCH4 Activation and Transmission of Signal to the NucleusNoncanonical activation of NOTCH3NOTCH2 Activation and Transmission of Signal to the Nucleus
MECANISMO DE DOENÇA

Alzheimer disease 4

A familial early-onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
24.2 TPM
Pituitária
23.2 TPM
Cerebelo
22.9 TPM
Esôfago - Muscular
22.6 TPM
Testículo
22.2 TPM
OUTRAS DOENÇAS (4)
dilated cardiomyopathy 1VAlzheimer disease 4familial isolated dilated cardiomyopathyearly-onset autosomal dominant Alzheimer disease
HGNC:9509UniProt:P49810
ABCC9ATP-binding cassette sub-family C member 9Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation (PubMed:9831708). Can form a sulfonylurea-sensitive but ATP-insensitive potassium channel with KCNJ8 (By similarity)

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisABC-family proteins mediated transportATP sensitive Potassium channels
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1O

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

OUTRAS DOENÇAS (7)
hypertrichotic osteochondrodysplasia Cantu typeintellectual disability and myopathy syndromeatrial fibrillation, familial, 12dilated cardiomyopathy 1O
HGNC:60UniProt:O60706
BAG3BAG family molecular chaperone regulator 3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Co-chaperone and adapter protein that connects different classes of molecular chaperones including heat shock proteins 70 (HSP70s), e.g. HSPA1A/HSP70 or HSPA8/HSC70, and small heat shock proteins (sHSPs), e.g. HSPB8 (PubMed:27884606, PubMed:30559338). Acts as a nucleotide-exchange factor (NEF) promoting the release of ADP from HSP70s, thereby triggering client protein release (PubMed:27884606, PubMed:30559338). Nucleotide release is mediated via BAG3 binding to the nucleotide-binding domain (NBD

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Regulation of HSF1-mediated heat shock response
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 6

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM6 is characterized by early-onset of severe, progressive, diffuse muscle weakness associated with cardiomyopathy, severe respiratory insufficiency during adolescence, and a rigid spine in some patients.

OUTRAS DOENÇAS (5)
myofibrillar myopathy 6dilated cardiomyopathy 1HHCharcot-Marie-tooth disease, axonal, type 2JJneuronopathy, distal hereditary motor, autosomal dominant 15
HGNC:939UniProt:O95817
TXNRD2Thioredoxin reductase 2, mitochondrialDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Involved in the control of reactive oxygen species levels and the regulation of mitochondrial redox homeostasis (PubMed:24601690). Maintains thioredoxin in a reduced state. May play a role in redox-regulated cell signaling

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Detoxification of Reactive Oxygen Species
MECANISMO DE DOENÇA

Glucocorticoid deficiency 5

A form of glucocorticoid deficiency, a rare autosomal recessive disorder characterized by resistance to ACTH action on the adrenal cortex, adrenal insufficiency and an inability of the adrenal cortex to produce cortisol. It usually presents in the neonatal period or in early childhood with episodes of hypoglycemia and other symptoms related to cortisol deficiency, including failure to thrive, recurrent illnesses or infections, convulsions, and shock. In a small number of patients hypoglycemia can be sufficiently severe and persistent that it leads to serious long-term neurological damage or death. The diagnosis is readily confirmed with a low plasma cortisol measurement in the presence of an elevated ACTH level, and normal aldosterone and plasma renin measurements.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
32.0 TPM
Cérebro - Hemisfério cerebelar
31.1 TPM
Glândula adrenal
24.7 TPM
Próstata
23.1 TPM
Nervo tibial
19.6 TPM
OUTRAS DOENÇAS (3)
glucocorticoid deficiency 5familial isolated dilated cardiomyopathyfamilial glucocorticoid deficiency
HGNC:18155UniProt:Q9NNW7
MYH7Myosin-7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle

LOCALIZAÇÃO

Cytoplasm, myofibrilCytoplasm, myofibril, sarcomere

MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 1

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
4513.7 TPM
Músculo esquelético
3692.8 TPM
Coração - Átrio
592.2 TPM
Pâncreas
5.3 TPM
Hipotálamo
4.9 TPM
OUTRAS DOENÇAS (12)
MYH7-related skeletal myopathymyopathy, myosin storage, autosomal recessivedilated cardiomyopathy 1Scongenital myopathy 7A, myosin storage, autosomal dominant
HGNC:7577UniProt:P12883
TPM1Tropomyosin alpha-1 chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds to actin filaments in muscle and non-muscle cells (PubMed:23170982). Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction (PubMed:23170982). Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (2)
Smooth Muscle ContractionStriated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 3

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
1299.6 TPM
Esôfago - Muscular
1291.9 TPM
Cólon sigmoide
992.0 TPM
Esôfago - Junção
988.7 TPM
Coração - Átrio
959.4 TPM
OUTRAS DOENÇAS (4)
dilated cardiomyopathy 1Yhypertrophic cardiomyopathy 3familial isolated dilated cardiomyopathyleft ventricular noncompaction
HGNC:12010UniProt:P09493
TAFAZZINTafazzinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acyltransferase required to remodel newly synthesized phospholipid cardiolipin (1',3'-bis-[1,2-diacyl-sn-glycero-3-phospho]-glycerol or CL), a key component of the mitochondrial inner membrane, with tissue specific acyl chains necessary for adequate mitochondrial function (PubMed:12930833, PubMed:19164547, PubMed:19700766, PubMed:26908608, PubMed:33096711). Its role in cellular physiology is to improve mitochondrial performance (PubMed:32234310). CL is critical for the coassembly of lipids and p

LOCALIZAÇÃO

Mitochondrion outer membraneMitochondrion inner membraneMitochondrion membraneCytoplasm

VIAS BIOLÓGICAS (2)
Acyl chain remodeling of CLMitochondrial protein import
MECANISMO DE DOENÇA

Barth syndrome

An X-linked disease characterized by dilated cardiomyopathy with endocardial fibroelastosis, a predominantly proximal skeletal myopathy, growth retardation, neutropenia, and organic aciduria, particularly excess of 3-methylglutaconic acid. Additional features include hypertrophic cardiomyopathy, isolated left ventricular non-compaction, ventricular arrhythmia, motor delay, poor appetite, fatigue and exercise intolerance, hypoglycemia, lactic acidosis, hyperammonemia, and dramatic late catch-up growth after growth delay throughout childhood.

OUTRAS DOENÇAS (2)
Barth syndromefamilial isolated dilated cardiomyopathy
HGNC:11577UniProt:Q16635
MYH6Myosin-6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Muscle contraction

LOCALIZAÇÃO

Cytoplasm, myofibril

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Atrial septal defect 3

A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
4609.5 TPM
Coração - Ventrículo esquerdo
334.6 TPM
Músculo esquelético
53.3 TPM
Pituitária
5.7 TPM
Próstata
0.7 TPM
OUTRAS DOENÇAS (7)
atrial septal defect 3dilated cardiomyopathy 1EEhypertrophic cardiomyopathy 14atrial septal defect, ostium secundum type
HGNC:7576UniProt:P13533

Variantes genéticas (ClinVar)

1,955 variantes patogênicas registradas no ClinVar.

🧬 SCN5A: NM_000335.5(SCN5A):c.41G>C (p.Arg14Pro) ()
🧬 SCN5A: NM_000335.5(SCN5A):c.3778T>G (p.Tyr1260Asp) ()
🧬 SCN5A: NM_000335.5(SCN5A):c.3569G>A (p.Trp1190Ter) ()
🧬 SCN5A: NM_000335.5(SCN5A):c.1873G>T (p.Glu625Ter) ()
🧬 SCN5A: NM_000335.5(SCN5A):c.938del (p.Asn313fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 5 variantes classificadas pelo ClinVar.

3
2
Patogênica (60.0%)
VUS (40.0%)
VARIANTES MAIS SIGNIFICATIVAS
LMOD2: NM_207163.3(LMOD2):c.273+1G>A [Pathogenic]
LDB3: NM_007078.3(LDB3):c.1594G>C (p.Ala532Pro) [Conflicting classifications of pathogenicity]
TNNT2: NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp) [Pathogenic/Likely pathogenic]
LDB3: NM_007078.3(LDB3):c.1633A>G (p.Ser545Gly) [Uncertain significance]
DSG2: NM_001943.5(DSG2):c.1361A>C (p.Asp454Ala) [Uncertain significance]

Vias biológicas (Reactome)

117 vias biológicas associadas aos genes desta condição.

Interaction between L1 and Ankyrins Phase 0 - rapid depolarisation PPARA activates gene expression Striated Muscle Contraction Ion homeostasis Respiratory electron transport Citric acid cycle (TCA cycle) Maturation of TCA enzymes and regulation of TCA cycle Platelet degranulation Nephrin family interactions Unblocking of NMDA receptors, glutamate binding and activation Ras activation upon Ca2+ influx through NMDA receptor RAF/MAP kinase cascade Assembly and cell surface presentation of NMDA receptors Negative regulation of NMDA receptor-mediated neuronal transmission Long-term potentiation Stimuli-sensing channels Rap1 signalling GP1b-IX-V activation signalling CD209 (DC-SIGN) signaling RAF activation MAP2K and MAPK activation Negative feedback regulation of MAPK pathway Negative regulation of MAPK pathway Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Signaling downstream of RAS mutants Signaling by RAF1 mutants SHOC2 M1731 mutant abolishes MRAS complex function Gain-of-function MRAS complexes activate RAF signaling IFNG signaling activates MAPKs Transcriptional regulation by RUNX2 Cardiogenesis Role of ABL in ROBO-SLIT signaling Apoptotic cleavage of cell adhesion proteins Keratinization Formation of the cornified envelope RAC2 GTPase cycle RHOG GTPase cycle RAC3 GTPase cycle Insertion of tail-anchored proteins into the endoplasmic reticulum membrane Formation of the dystrophin-glycoprotein complex (DGC) Matriglycan biosynthesis on DAG1 Coenzyme A biosynthesis Neutrophil degranulation RND3 GTPase cycle RND1 GTPase cycle Nuclear signaling by ERBB4 Degradation of the extracellular matrix Regulated proteolysis of p75NTR NRIF signals cell death from the nucleus Activated NOTCH1 Transmits Signal to the Nucleus Constitutive Signaling by NOTCH1 PEST Domain Mutants Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants NOTCH2 Activation and Transmission of Signal to the Nucleus EPH-ephrin mediated repulsion of cells NOTCH3 Activation and Transmission of Signal to the Nucleus NOTCH4 Activation and Transmission of Signal to the Nucleus Noncanonical activation of NOTCH3 TGFBR3 PTM regulation PKMTs methylate histone lysines Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 Meiotic synapsis Nuclear Envelope Breakdown Initiation of Nuclear Envelope (NE) Reformation Breakdown of the nuclear lamina XBP1(S) activates chaperone genes Depolymerization of the Nuclear Lamina Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models SIRT1 negatively regulates rRNA expression NoRC negatively regulates rRNA expression B-WICH complex positively regulates rRNA expression RNA Polymerase I Transcription Initiation RNA Polymerase I Promoter Escape RNA Polymerase I Transcription Termination RHOA GTPase cycle RHOB GTPase cycle Regulation of CDH1 Function HSF1-dependent transactivation L13a-mediated translational silencing of Ceruloplasmin expression Peptide chain elongation SRP-dependent cotranslational protein targeting to membrane Viral mRNA Translation Selenocysteine synthesis Major pathway of rRNA processing in the nucleolus and cytosol Formation of a pool of free 40S subunits GTP hydrolysis and joining of the 60S ribosomal subunit Eukaryotic Translation Termination Regulation of expression of SLITs and ROBOs Response of EIF2AK4 (GCN2) to amino acid deficiency Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA Regulation of HSF1-mediated heat shock response Ion transport by P-type ATPases Synthesis of dolichyl-phosphate Defective DOLK causes DOLK-CDG Smooth Muscle Contraction Signaling by ALK fusions and activated point mutants High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells Non-integrin membrane-ECM interactions Laminin interactions ECM proteoglycans MET activates PTK2 signaling Attachment of bacteria to epithelial cells Developmental Lineage of Pancreatic Ductal Cells ATP sensitive Potassium channels ABC-family proteins mediated transport Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome Detoxification of Reactive Oxygen Species Mitochondrial protein import Acyl chain remodeling of CL

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Miocardiopatia dilatada isolada familiar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
0 papers (10 anos)
#1

A rare case report of familial glucocorticoid deficiency type 4 (GCCD4) with dilated cardiomyopathy: a 3-year follow-up study.

Translational pediatrics2026 Feb 28

Familial glucocorticoid deficiency type 4 (GCCD4), caused by nicotinamide nucleotide transhydrogenase (NNT) gene mutations, represents a rare multisystem disorder with poorly characterized cardiac manifestations. A 12-year-old female presented with recurrent fatigue, syncope, and severe arrhythmias. After multiple misdiagnoses [including dilated cardiomyopathy, fulminant myocarditis, and long QT syndrome (LQTS)], comprehensive evaluation revealed hypocortisolism (<1.0 µg/dL), markedly elevated adrenocorticotropic hormone (ACTH) (>1,250 pg/mL), and hypothyroidism. Genetic testing identified compound heterozygous NNT mutations (c.639_640insC/p.Val214Argfs*32 and c.2764C>T/p.Arg922*). Comprehensive whole-exome sequencing (WES) ruled out pathogenic variants in genes associated with isolated cardiomyopathy or congenital hypothyroidism. Cardiac assessment showed left ventricular dilation [left ventricular end-diastolic diameter (LVEDD) 5.14 cm], reduced left ventricular ejection fraction (LVEF) 53%, and corrected QT interval (QTc) prolongation (559 ms) with torsades de pointes. The patient was managed with hormone replacement (hydrocortisone 8.8→16.1 mg/m2/day; levothyroxine 16.7 µg/day) and cardioprotective therapy (propranolol, captopril, coenzyme Q10), resulting in significant improvement at 3-year follow-up: ejection fraction (EF) normalized to 68%, thyroid function recovered permitting levothyroxine discontinuation, hyperpigmentation resolved completely, and no arrhythmias recurred. This case underscores GCCD4 as a differential diagnosis in pediatric cardiomyopathy with arrhythmias. Multidisciplinary collaboration and early genetic testing are critical for diagnosis. Individualized glucocorticoid dosing combined with cardiac support enables favorable outcomes.

#2

Clinical Spectrum of Arrhythmogenic Entities in Spanish Children Carrying Deleterious SCN5A Variants.

International journal of molecular sciences2026 Jan 15

Deleterious variants in SCN5A lead to a wide clinical spectrum that includes pathologies characterized by life-threatening cardiac events (CEs). In the pediatric population, early identification, management, and risk stratification of these pathologies are the main current challenges. This study analyzed a Spanish pediatric cohort (≤18 years) carrying rare SCN5A variants to explore genotype-phenotype correlations. A retrospective descriptive cohort study, including clinical, demographic, and genetic data of probands and their relatives, was conducted. Out of 100 children studied, 69 had definitively deleterious SCN5A variants (26 females, 38%; median age: 3 years, IQR 1-12). The main diagnoses were isolated Brugada syndrome (BrS) (31; 45%); isolated long QT syndrome type 3 (LQT3) (5; 7%); isolated progressive cardiac conduction disease (PCCD) (1; 2%); isolated familial atrial fibrillation (1; 2%); overlapping phenotypes (7; 10%) including: BrS-PCCD (2; 2.8%); BrS-LQT3 (1; 1.4%); premature ventricular contraction-dilated cardiomyopathy (1; 1.4%); BrS-LQT3-PCCD (1; 1.4%); BrS-PCCD-sick sinus syndrome (SSS) (1; 1.4%) and BrS-PCCD-SSS-familial atrial fibrillation (1; 1.4%). Of them, 13 (19%) patients presented with CEs (cardiogenic syncope, ventricular tachycardia/fibrillation, sudden cardiac arrest/death, and appropriate implantable cardio defibrillator shock). These findings underscore the utility of genetic testing for early diagnosis, risk stratification, and personalized management, enhancing preventive strategies for CE prevention in pediatrics.

#3

Dystrophin-Deficient Cardiomyopathy Due to a Novel Hemizygous DMD Indel Variant.

JACC. Case reports2026 Mar 11

Variants of dystrophin can lead to diverse phenotypes, ranging from isolated cardiomyopathy to aggressive Duchenne muscular dystrophy with progressive skeletal muscle weakness. We present a case of dystrophin-deficient cardiomyopathy in a 36-year-old man who presented in cardiogenic shock due to severe dilated cardiomyopathy requiring a bridge-to-transplant left ventricular assist device Genetic testing identified a DMD c.4857_4859del variant of uncertain significance. After heart transplantation, immunohistochemistry of the explanted heart revealed markedly reduced dystrophin staining, suggesting that the variant is disease-causing. Cascade testing identified multiple family members who were affected. This case report underscores the importance of synthesizing the clinical phenotype with functional testing to classify cardiomyopathy gene variants accurately. Periodic review of variants of uncertain significance is critical to enable early diagnosis, treatment, and family screening.

#4

Dilated Cardiomyopathy and Later Onset Limb-Girdle Muscular Dystrophy Associated With Fukutin and LaminA/C Mutations.

JACC. Case reports2026 Feb 20

Nonischemic dilated cardiomyopathy (DCM) can result from pathogenic variants in genes affecting myocardial structure and function. FKTN and LMNA mutations may involve both cardiac and skeletal muscle, consistent with limb-girdle muscular dystrophy (LGMD), with cardiac disease sometimes preceding neuromuscular symptoms. We report on 2 adults presenting with advanced DCM requiring heart transplantation, who were later diagnosed with LGMD. A 22-year-old woman had biallelic FKTN variants, and a 37-year-old man carried a heterozygous LMNA pathogenic variant. Both had elevated creatine kinase prior to proximal muscle weakness. Muscle biopsy and genetic testing confirmed dystrophic processes. These cases demonstrate that genetically mediated DCM may initially present as isolated cardiac disease. Early genetic testing can guide transplant planning, long-term care, and family counseling.

#5

Cardiac CT fractal analysis of LV noncompaction and common cardiomyopathies.

Journal of cardiovascular computed tomography2026

Left ventricular noncompaction (LVNC), or hypertrabeculation, is a myocardial condition that remains challenging to diagnose and differentiate from other cardiomyopathies. This study evaluated the ability of cardiac CT to differentiate between LVNC, hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and controls using fractal analysis of LV trabeculae. Subjects with LVNC, HCM, DCM, as well as controls, who underwent coronary CT angiography were included. LV trabecular structure was quantified using fractal analysis on a stack of 15 short-axis CT images. For each subject, maximum (FDmax) and average (FDglobal) fractal dimensions were reported. A subset of subjects also had clinically acquired cardiac MRI (CMR) exams for comparison. One-way ANOVA, Pearson correlation, and Bland-Altman analysis were used for statistical analysis. The study included 313 subjects (median age: 58.8 [48.1-68.0] years, 153 male) categorized into Control (89), LVNC (46), HCM (106), and DCM (72) cohorts. FDmax was significantly higher in LVNC (1.379 ​± ​0.047) than in Control (1.305 ​± ​0.033), HCM (1.321 ​± ​0.040), and DCM (1.344 ​± ​0.054) cohorts; all p ​< ​0.001. Similarly, FDglobal was significantly higher in LVNC (1.279 ​± ​0.041) than in the other cohorts; all p ​< ​0.05. In a subset of 132 subjects with both CT and CMR exams, fractal dimensions from the two modalities were strongly correlated (r ​= ​0.63, p ​< ​0.0001), with CT-derived values being higher (1.337 ​± ​0.049 vs. 1.262 ​± ​0.045, p ​< ​0.0001). CT-derived fractal dimensions of LV trabecular structure were significantly higher in LVNC compared to control subjects, HCM, and DCM. CT-derived fractal dimensions strongly correlated with, but were higher than, those from cardiac MRI in the same subjects.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 92

2026

Dystrophin-Deficient Cardiomyopathy Due to a Novel Hemizygous DMD Indel Variant.

JACC. Case reports
2026

A rare case report of familial glucocorticoid deficiency type 4 (GCCD4) with dilated cardiomyopathy: a 3-year follow-up study.

Translational pediatrics
2026

Dilated Cardiomyopathy and Later Onset Limb-Girdle Muscular Dystrophy Associated With Fukutin and LaminA/C Mutations.

JACC. Case reports
2026

Clinical Spectrum of Arrhythmogenic Entities in Spanish Children Carrying Deleterious SCN5A Variants.

International journal of molecular sciences
2025

Atrial Dilated Cardiomyopathy: From Molecular Pathogenesis to Clinical Implications.

Journal of clinical medicine
2025

Genetic and Clinical Characterization of FLNC Variants in Chinese Patients with Cardiomyopathy.

Journal of cardiovascular development and disease
2025

[When rarity duplicates: myocardial non-compaction and single coronary artery, an association not to be underestimated].

Giornale italiano di cardiologia (2006)
2026

Cardiac CT fractal analysis of LV noncompaction and common cardiomyopathies.

Journal of cardiovascular computed tomography
2025

NPPA-Associated Atrial Dilated Cardiomyopathy: Genotypic and Phenotypic Insights From an Ultrarare Inherited Disorder.

JACC. Case reports
2025

Recurrent nonsense p.Trp3416* variant in the DMD gene identified in healthy Lebanese individuals: Implications for variant classification and genotype-phenotype correlations.

Journal of neuromuscular diseases
2025

Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

medRxiv : the preprint server for health sciences
2025

Disease spectrum and long-term prognosis of patients with BAG3-associated neuromuscular diseases in Europe.

Brain : a journal of neurology
2025

Sauchinone preserves cardiac function in doxorubicin-induced cardiomyopathy by inhibiting the NLRP3 inflammasome.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2025

EMD missense variant causes X-linked isolated dilated cardiomyopathy with myocardial emerin deficiency.

European journal of human genetics : EJHG
2025

Sudden cardiac death, arrhythmogenic cardiomyopathy and intercalated disc pathology due to reduced filamin C protein levels: a matter of life and death.

Human molecular genetics
2025

A single RBM20 missense variant is a potential contributor to dilated cardiomyopathy and/or isolated left ventricular dilatation in the Emilia Romagna region of Italy.

International journal of cardiology
2024

Arrhythmias May Hide a Genetic Cardiomyopathy in Left Ventricular Hypertrabeculation in Children: A Single-Center Experience.

Children (Basel, Switzerland)
2024

Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation.

Stem cell research &amp; therapy
2024

Neuromuscular and cardiovascular phenotypes in paediatric titinopathies: a multisite retrospective study.

Journal of medical genetics
2024

Perivascular Basal Echogenicity in the Fetal Heart: An Unconventional Marker of Maternal Autoimmune Antibodies.

Pediatric cardiology
2024

Variable phenotype of a null PPP1R13L allele in children with dilated cardiomyopathy.

American journal of medical genetics. Part A
2023

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene.

Frontiers in pediatrics
2023

Functional defects in hiPSCs-derived cardiomyocytes from patients with a PLEKHM2-mutation associated with dilated cardiomyopathy and left ventricular non-compaction.

Biological research
2023

TRPA1 deficiency aggravates dilated cardiomyopathy by promoting S100A8 expression to induce M1 macrophage polarization in rats.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2023

Lem2 is essential for cardiac development by maintaining nuclear integrity.

Cardiovascular research
2023

Exosomes mediated fibrogenesis in dilated cardiomyopathy through a MicroRNA pathway.

iScience
2022

Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy.

Journal of the American College of Cardiology
2023

Dominantly acting KIF5B variants with pleiotropic cellular consequences cause variable clinical phenotypes.

Human molecular genetics
2022

Dilated-Left Ventricular Non-Compaction Cardiomyopathy in a Pediatric Case with SPEG Compound Heterozygous Variants.

International journal of molecular sciences
2022

Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.

European journal of translational myology
2022

A Case of Severe Left-Ventricular Noncompaction Associated with Splicing Altering Variant in the FHOD3 Gene.

Genes
2022

Left Ventricular Noncompaction Cardiomyopathy: Left Ventricular Dilation and Dysfunction at Baseline Portend the Risk of Death or Heart Transplantation.

The Canadian journal of cardiology
2021

A combinatorial oligogenic basis for the phenotypic plasticity between late-onset dilated and arrhythmogenic cardiomyopathy in a single family.

The journal of cardiovascular aging
2021

Integrated regulatory network based on lncRNA-miRNA-mRNA-TF reveals key genes and sub-networks associated with dilated cardiomyopathy.

Computational biology and chemistry
2021

Case Report: Novel Likely Pathogenic ACTN2 Variant Causing Heterogeneous Phenotype in a Korean Family With Left Ventricular Non-compaction.

Frontiers in pediatrics
2021

[Familial left ventricular noncompaction: phenotypes and clinical course. Results of the multicenter registry].

Terapevticheskii arkhiv
2021

Cardiac-Specific Deletion of Orai3 Leads to Severe Dilated Cardiomyopathy and Heart Failure in Mice.

Journal of the American Heart Association
2021

CELF1 promotes vascular endothelial growth factor degradation resulting in impaired microvasculature in heart failure.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2021

The Desmin (DES) Mutation p.A337P Is Associated with Left-Ventricular Non-Compaction Cardiomyopathy.

Genes
2020

Phosphorylated cofilin-2 is more prone to oxidative modifications on Cys39 and favors amyloid fibril formation.

Redox biology
2020

LMNA Missense Mutation Causes Nonsense-Mediated mRNA Decay and Severe Dilated Cardiomyopathy.

Circulation. Genomic and precision medicine
2020

Different Manifestations in Familial Isolated Left Ventricular Non-compaction: Two Case Reports and Literature Review.

Frontiers in pediatrics
2020

Infections in children with left ventricular assist device.

Transplant infectious disease : an official journal of the Transplantation Society
2020

Cardiac Emerinopathy: A Nonsyndromic Nuclear Envelopathy With Increased Risk of Thromboembolic Stroke Due to Progressive Atrial Standstill and Left Ventricular Noncompaction.

Circulation. Arrhythmia and electrophysiology
2020

A novel homozygous TPM1 mutation in familial pediatric hypertrophic cardiomyopathy and in silico screening of potential targeting drugs.

European review for medical and pharmacological sciences
2020

The Broad Spectrum of LMNA Cardiac Diseases: From Molecular Mechanisms to Clinical Phenotype.

Frontiers in physiology
2020

SOS1 Gain-of-Function Variants in Dilated Cardiomyopathy.

Circulation. Genomic and precision medicine
2020

Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies.

ESC heart failure
2020

Family screening in black patients with isolated left ventricular non-compaction: the Chris Hani Baragwanath experience.

Cardiovascular journal of Africa
2020

Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers.

Molecular genetics &amp; genomic medicine
2020

ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy.

Annals of neurology
2019

Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy - a pilot study.

Scientific reports
2020

Left ventricular noncompaction - Risk stratification and genetic consideration.

Journal of cardiology
2019

Disruption of cardiac thin filament assembly arising from a mutation in LMOD2: A novel mechanism of neonatal dilated cardiomyopathy.

Science advances
2019

Left Ventricular Noncompaction: Cause or Consequence of Myocardial Disease? A Case Report and Literature Review.

Cardiology
2019

A novel de novo CASZ1 heterozygous frameshift variant causes dilated cardiomyopathy and left ventricular noncompaction cardiomyopathy.

Molecular genetics &amp; genomic medicine
2019

FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations.

Clinical genetics
2019

Heterozygous Mylk3 Knockout Mice Partially Recapitulate Human DCM With Heterozygous MYLK3 Mutations.

Frontiers in physiology
2019

Patients with Isolated Focal Right Ventricular Dyskinetic Segments: Toward a Better Understanding of This Cohort.

Journal of cardiovascular imaging
2019

Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.

Parkinsonism &amp; related disorders
2019

Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.

Journal of the American College of Cardiology
2019

Inhibition of the Hypoxia-Inducible Factor 1α-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.

Circulation
2019

Alström Syndrome Presenting as Isolated Dilated Cardiomyopathy.

Indian journal of pediatrics
2018

Characterization of rhinovirus C from a 4-year-old boy with acute onset dilated cardiomyopathy in Jakarta, Indonesia.

JMM case reports
2019

Genetic architecture of recent-onset dilated cardiomyopathy in Moravian region assessed by whole-exome sequencing and its clinical correlates.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
2018

Clinical and Echocardiographic Impact of Tafazzin Variants on Dilated Cardiomyopathy Phenotype in Left Ventricular Non-Compaction Patients in Early Infancy.

Circulation journal : official journal of the Japanese Circulation Society
2017

Three new cases of dilated cardiomyopathy caused by mutations in LMNA gene.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
2019

Atrial fibrillation in patients with inherited cardiomyopathies.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2018

Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy.

Circulation. Heart failure
2018

Clinical application of targeted next-generation sequencing in fetuses with congenital heart defect.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2018

Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation.

Journal of the American Heart Association
2018

The pathogenic gene screening in a Chinese familial dilated cardiomyopathy pedigree from Hubei.

Gene
2017

Clinical spectrum of woolly hair: indications for cerebral involvement.

Italian journal of pediatrics
2017

A Dutch MYH7 founder mutation, p.(Asn1918Lys), is associated with early onset cardiomyopathy and congenital heart defects.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
2017

The structural basis of alpha-tropomyosin linked (Asp230Asn) familial dilated cardiomyopathy.

Journal of molecular and cellular cardiology
2017

Exome Sequencing Identifies a Novel DES Mutation (R227C) in a Chinese Dilated Cardiomyopathy Family.

Cardiology
2016

Adeno-associated Virus Serotype 9 - Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts with Left Ventricular Dysfunction Secondary to a Myocardial Infarction.

JACC. Basic to translational science
2017

Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRRβ.

American journal of physiology. Heart and circulatory physiology
2017

Long-Term Biased β-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy.

Circulation
2017

Co segregation of the m.1555A>G mutation in the MT-RNR1 gene and mutations in MT-ATP6 gene in a family with dilated mitochondrial cardiomyopathy and hearing loss: A whole mitochondrial genome screening.

Biochemical and biophysical research communications
2017

Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy.

Archives of biochemistry and biophysics
2016

Mutation of a common amino acid in NKX2.5 results in dilated cardiomyopathy in two large families.

BMC medical genetics
2016

Inhibition of late sodium current attenuates ionic arrhythmia mechanism in ventricular myocytes expressing LaminA-N195K mutation.

Heart rhythm
2017

Whole-Exome Sequencing Identifies Two Novel TTN Mutations in Chinese Families with Dilated Cardiomyopathy.

Cardiology
2016

Two novel MYH7 proline substitutions cause Laing Distal Myopathy-like phenotypes with variable expressivity and neck extensor contracture.

BMC medical genetics
2016

Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: Report on nine patients.

Molecular genetics and metabolism
2016

Pivotal Role of Regulator of G-protein Signaling 12 in Pathological Cardiac Hypertrophy.

Hypertension (Dallas, Tex. : 1979)
2015

PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction.

Human molecular genetics
2016

A high frequency of viral agents yet absence of Borrelia burgdorferi is seen within the myocardium of subjects with normal left ventricular systolic function: an electron microscopy study.

Folia microbiologica
2015

Left ventricular noncompaction in a family with lamin A/C gene mutation.

Texas Heart Institute journal
2015

Health Status and Psychological Distress in Patients with Non-compaction Cardiomyopathy: The Role of Burden Related to Symptoms and Genetic Vulnerability.

International journal of behavioral medicine
2014

Sustained ventricular tachycardia in a patient with isolated non-compaction cardiomyopathy.

Cardiovascular journal of Africa

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Miocardiopatia dilatada isolada familiar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Miocardiopatia dilatada isolada familiar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A rare case report of familial glucocorticoid deficiency type 4 (GCCD4) with dilated cardiomyopathy: a 3-year follow-up study.
    Translational pediatrics· 2026· PMID 41810200mais citado
  2. Clinical Spectrum of Arrhythmogenic Entities in Spanish Children Carrying Deleterious SCN5A Variants.
    International journal of molecular sciences· 2026· PMID 41596527mais citado
  3. Dystrophin-Deficient Cardiomyopathy Due to a Novel Hemizygous DMD Indel Variant.
    JACC. Case reports· 2026· PMID 41817254mais citado
  4. Dilated Cardiomyopathy and Later Onset Limb-Girdle Muscular Dystrophy Associated With Fukutin and LaminA/C Mutations.
    JACC. Case reports· 2026· PMID 41718518mais citado
  5. Cardiac CT fractal analysis of LV noncompaction and common cardiomyopathies.
    Journal of cardiovascular computed tomography· 2026· PMID 40846526mais citado
  6. Characteristics of gene mutations in Vietnamese pediatric patients with Inborn Errors of Immunity: a cross-sectional study.
    Orphanet J Rare Dis· 2026· PMID 41723525recente
  7. Medical expenses and care pathways of patients with Pompe receiving myozyme: an observational study based on the French national healthcare database.
    Orphanet J Rare Dis· 2025· PMID 41174634recente
  8. Impact of brief telehealth interventions on parental stress and challenging behaviors of children with fragile X syndrome.
    Orphanet J Rare Dis· 2025· PMID 40993733recente
  9. Research trends and hotspots of adult Alagille syndrome: a bibliometric analysis.
    Orphanet J Rare Dis· 2025· PMID 40597401recente
  10. The clinical phenotypes and therapeutic strategies for stiff skin syndrome: a case series with literature review.
    Orphanet J Rare Dis· 2025· PMID 40551142recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:154(Orphanet)
  2. MONDO:0700335(MONDO)
  3. Variantes catalogadas(ClinVar)
  4. Busca completa no PubMed(PubMed)
  5. Q56013726(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Miocardiopatia dilatada isolada familiar
Compêndio · Raras BR

Miocardiopatia dilatada isolada familiar

ORPHA:154 · MONDO:0700335
Prevalência
1-5 / 10 000
Herança
Autosomal dominant, Autosomal recessive, Mitochondrial inheritance, X-linked recessive
CID-10
I42.0 · Cardiomiopatia dilatada
CID-11
Início
All ages
Prevalência
17.5 (Europe)
MedGen
UMLS
C0340427
Repurposing
1 candidato
dexrazoxanechelating agent|topoisomerase inhibitor
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades